Sponsor

Amneal Pharmaceuticals, LLC

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Amneal Pharmaceuticals, LLC appears in 7 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials7
Recruiting shown4
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

7 shown
Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.NCT05401357 · lead sponsor · 2022-06-29
RECRUITING
A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both EyesNCT06267274 · lead sponsor · 2024-04-01
UNKNOWN
BE Study in Patients - Methotrexate TabletsNCT02940561 · lead sponsor · 2016-08-01
UNKNOWN
Bioequivalence Fasting Study in PatientsNCT02072954 · lead sponsor · 2013-11-01
COMPLETED
BOOST-PD A Naturalistic Study on IPX-203 for Parkinson's DiseaseNCT07138560 · collaborator · 2025-07-24
RECRUITING
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's DiseaseNCT06765668 · collaborator · 2025-02-12
RECRUITING
Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People.NCT00404989 · collaborator · 1989-01-01
RECRUITING

Sponsor roles

lead sponsor4
collaborator3

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.